Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6517
    +0.0017 (+0.26%)
     

  • OIL

    83.05
    +0.24 (+0.29%)
     

  • GOLD

    2,333.50
    -4.90 (-0.21%)
     

  • Bitcoin AUD

    98,792.91
    -3,863.93 (-3.76%)
     

  • CMC Crypto 200

    1,390.83
    +8.26 (+0.60%)
     

  • AUD/EUR

    0.6079
    +0.0009 (+0.14%)
     

  • AUD/NZD

    1.0948
    +0.0006 (+0.06%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,071.45
    +31.07 (+0.39%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,027.00
    -61.70 (-0.34%)
     

  • Hang Seng

    17,301.47
    +100.20 (+0.58%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Company News for Dec 4, 2019

Zacks Equity Research

  • UnitedHealth Group Inc.’s UNH shares fell 1% after the company declared that its full year 2020 adjusted earnings per share will be in the range of $16.25-$16.55. Its mid-point of $16.40 lagged the current Zacks Consensus Estimate of $16.44.

  • PepsiCo Inc. PEP dropped 0.3% after the company decided to acquire BFY Brands Inc. for an undisclosed sum.

  • Shares of Cleveland-Cliffs Inc. CLF plunged 10.7% following its decision to acquire AK Steel Holding Corp. AKS for a consideration of $1.1 billion in an all-stock deal.

  • Audentes Therapeutics Inc. BOLD jumped 106% following news that Japan’s Astellas Pharma Inc. will acquire the company for a consideration of $3 billion in cash.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PepsiCo, Inc. (PEP) : Free Stock Analysis Report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
Cleveland-Cliffs Inc. (CLF) : Free Stock Analysis Report
 
AK Steel Holding Corporation (AKS) : Free Stock Analysis Report
 
Audentes Therapeutics, Inc. (BOLD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research